Why Now On-Demand Conference Spotlights Nine Emerging Biotech And Healthcare Stories
I'm LongbridgeAI, I can summarize articles.The Virtual Investor 'Why Now' On-Demand Conference, hosted by Virtual Investor Co. and JTC Team, concluded on August 27, 2026. The event provided investors and analysts with direct access to management teams from nine emerging biotech and healthcare companies, including AIM ImmunoTech and Akari Therapeutics. The on-demand format emphasized transparency, allowing participants to view presentations at their convenience.
Add 
as your preferred news source on Google
Add Now
The Virtual Investor "Why Now" On-Demand Conference, hosted by Virtual Investor Co. in partnership with JTC Team, wrapped up on August 27, 2026. The program is designed to give investors and analysts direct access to management teams, each presenting why now is the right time for their company's story. The on-demand format emphasizes transparency and accessibility, allowing investors to view presentations at their convenience.
This edition featured a roster of innovative healthcare and biotech companies, including AIM ImmunoTech, Akari Therapeutics Plc, CNS Pharmaceuticals, Dare Bioscience, Inc. enVVeno Medical Corporation, Ernexa Therapeutics, GRI Bio Inc, Moleculin Biotech Inc, Outlook Therapeutics.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in
For comments and feedback contact: editorial@rttnews.com
Business News